K-582, a new peptide antibiotic. I

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Antibiotic resistance is a growing global health concern, necessitating the discovery of new antimicrobial agents.
• Peptide antibiotics represent a promising class of therapeutics due to their unique mechanisms of action and potential for reduced resistance development.

Purpose of the Study:

• To isolate, purify, and characterize a novel basic peptide antibiotic, designated K-582.
• To evaluate the antimicrobial spectrum and toxicity of K-582.

Main Methods:

• Isolation and purification of K-582 using chromatographic techniques (Al2O3, Biol-Gel P-2, CM Sephadex).
• Characterization of K-582 A and K-582 B using nitrogen content analysis, color reactions, and spectroscopic methods (IR, 1H NMR, C-13 NMR).
• Antimicrobial susceptibility testing against various microorganisms and toxicity assessment in mice.

Main Results:

• Two major peptide fractions, K-582 A and K-582 B, were successfully isolated and purified from K-582.
• Spectroscopic and chemical analyses confirmed the peptide nature of K-582 A and K-582 B.
• K-582 demonstrated significant efficacy against yeasts but was inactive against Gram-positive bacteria, Gram-negative bacteria, and Mycobacterium. The antibiotic exhibited low toxicity in murine models.

Conclusions:

• The novel basic peptide antibiotic K-582, comprising fractions K-582 A and K-582 B, possesses significant antifungal activity.
• K-582's selective activity against yeasts and low toxicity suggest its potential as a therapeutic agent for yeast infections.